Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_assertion type Assertion NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_head.
- NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_provenance.
- NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_assertion evidence source_evidence_literature NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_provenance.
- NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_assertion SIO_000772 23233573 NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_provenance.
- NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_assertion wasDerivedFrom befree-20150227 NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_provenance.
- NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_assertion wasGeneratedBy ECO_0000203 NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_provenance.